Primary Endpoint Solutions (PES) is a GCP-compliant service provider supported by a team of drug discovery professionals and clinicians.
Lead by the same team as BioModels, PES was founded with the sole focus of improving clinical trial outcomes. Aiming to reduce Phase III clinical trial failures for promising therapeutics, the PES team’s goal is to provide you with consistent clinical practice standards, trained raters, and specific endpoint criteria to allow for reliable and interpretable data across all your sites and investigators.
OPTIMIZING CLINICAL TRIALS
PES supports clinical trials by focusing on quality endpoint data; providing your pipeline assets with the fairest opportunity to demonstrate efficacy, gain approval, and enter the market.
Expertise in several key trial domains, including:
Study Design and Endpoint Selection | Expert clinicians assist in the selection of study endpoints with careful consideration of the clinical, regulatory, and commercial importance. |
Study Metrics | PES provides CROs with metrics designed to optimize study subject retention and accrual as well as dropout monitoring and analysis. |
Customized Web-Based Training | Custom web-based training modules, designed to optimize data collection accuracy and uniformity, are provided for all study personnel, translated to the local language of each study site. |
Real-Time Data Quality Review | Real-time EdQ™ assessment of every subject observation focused on completeness and consistency; any observed gaps are flagged, and sites are immediately contacted. |
Centralized Scoring and Grading of Patient Assessments | All patient observations are reviewed and assigned scores by an indication expert at PES, removing site- and clinician-based variability. |
Let the PES team organize, train, and facilitate these details, maximizing the likelihood of your trial’s success.
For more information visit pesclinical.com or contact us here!